News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Astley-Sparke Philip
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/18/2023 |
4
| Astley-Sparke Philip (CEO) has filed a Form 4 on Replimune Group, Inc.
Txns:
| Sold 17,902 shares
@ $18.05, valued at
$323.1k
|
|
04/04/2023 |
4
| Astley-Sparke Philip (CEO) has filed a Form 4 on Replimune Group, Inc.
Txns:
| Granted 142,100 shares
@ $0 Granted 213,150 options to buy
@ $17.66, valued at
$3.8M
|
|
05/18/2022 |
4
| Astley-Sparke Philip (CEO) has filed a Form 4 on Replimune Group, Inc.
Txns:
| Sold 9,632 shares
@ $14.59, valued at
$140.5k
|
|
04/05/2022 |
4
| Astley-Sparke Philip (CEO) has filed a Form 4 on Replimune Group, Inc.
Txns:
| Granted 70,000 shares
@ $0 Granted 105,000 options to buy
@ $18.26, valued at
$1.9M
|
|
12/09/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/11/2020 |
4
| Astley-Sparke Philip (CEO) has filed a Form 4 on Replimune Group, Inc.
Txns:
| Sold 600 shares
@ $45.79, valued at
$27.5k
Sold 6,025 shares
@ $44.85, valued at
$270.2k
Sold 6,459 shares
@ $43.88, valued at
$283.4k
Sold 11,116 shares
@ $43.09, valued at
$479k
Sold 800 shares
@ $42.03, valued at
$33.6k
Sold 5,086 shares
@ $43.72, valued at
$222.4k
Sold 16,051 shares
@ $42.99, valued at
$690k
Sold 3,863 shares
@ $42.39, valued at
$163.8k
|
|
04/02/2020 |
4
| Astley-Sparke Philip (CEO) has filed a Form 4 on Replimune Group, Inc.
Txns:
| Granted 265,000 options to buy
@ $9.78, valued at
$2.6M
|
|
03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/08/2019 |
4
| Astley-Sparke Philip (Executive Chairman) has filed a Form 4 on Replimune Group, Inc.
Txns:
| Sold 14,500 shares
@ $17.02, valued at
$246.8k
Sold 14,500 shares
@ $17, valued at
$246.5k
|
|
11/06/2019 |
4
| Astley-Sparke Philip (Executive Chairman) has filed a Form 4 on Replimune Group, Inc.
Txns:
| Sold 14,500 shares
@ $17.052, valued at
$247.3k
Sold 14,500 shares
@ $17, valued at
$246.5k
|
|
11/04/2019 |
4
| Astley-Sparke Philip (Executive Chairman) has filed a Form 4 on Replimune Group, Inc.
Txns:
| Sold 14,500 shares
@ $17, valued at
$246.5k
|
|
09/25/2019 |
4
| Astley-Sparke Philip (Executive Chairman) has filed a Form 4 on Replimune Group, Inc.
Txns:
| Sold 14,500 shares
@ $17.05, valued at
$247.2k
|
|
08/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/04/2019 |
4
| Astley-Sparke Philip (Director) has filed a Form 4 on uniQure N.V.
Txns:
| Sold 400 shares
@ $61.4, valued at
$24.6k
Sold 600 shares
@ $62.97, valued at
$37.8k
Sold 4,401 shares
@ $63.8, valued at
$280.8k
Sold 599 shares
@ $64.53, valued at
$38.7k
|
|
04/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/03/2019 |
4
| Astley-Sparke Philip (Director) has filed a Form 4 on uniQure N.V.
Txns:
| Sold 6,000 shares
@ $59.84, valued at
$359k
|
|
01/30/2019 |
4
| Astley-Sparke Philip (Director) has filed a Form 4 on uniQure N.V.
Txns:
| Sold 1,210 shares
@ $31.32, valued at
$37.9k
|
|
01/29/2019 |
4
| Astley-Sparke Philip (Director) has filed a Form 4 on uniQure N.V.
Txns:
| Granted 3,230 shares
@ $0 Granted 5,295 options to buy
@ $31.71, valued at
$167.9k
|
|
12/06/2018 |
4
| Astley-Sparke Philip (Director) has filed a Form 4 on uniQure N.V.
Txns:
| Sold 5,000 shares
@ $30.39, valued at
$152k
|
|
07/26/2018 |
4
| Astley-Sparke Philip (Executive Chairman) has filed a Form 4 on Replimune Group, Inc.
Txns:
| Granted 140,000 options to buy
@ $15, valued at
$2.1M
|
|
07/19/2018 |
3
| Astley-Sparke Philip (Executive Chairman) has filed a Form 3 on Replimune Group, Inc. |
01/31/2018 |
4
| Astley-Sparke Philip (Director) has filed a Form 4 on uniQure N.V.
Txns:
| Sold 6,540 shares
@ $18.53, valued at
$121.2k
|
|
01/30/2018 |
4
| Astley-Sparke Philip (Director) has filed a Form 4 on uniQure N.V.
Txns:
| Granted 4,792 shares
@ $0 Granted 6,390 options to buy
@ $19.39, valued at
$123.9k
|
|
01/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/04/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|